Thomas John, Managing Director, Agappe Diagnostics Limited

"The company is planning to enter areas like immunology, microbiology, and urine analysis and come out with four to five different types of products which could be import substitutes."

Thomas John
Managing Director,
Agappe Diagnostics Limited

Agappe Diagnostics' minority stake of 20.24 percent has been acquired by Konark Capital for Rs.50 crore. The investment was routed through Konark's investment fund Sycamore Holdings Mauritius, and Veda Corporate Advisors acted as advisors to Agappe Diagnostic on this deal.

Agappe Diagnostics is planning for the expansion of its production facility and product portfolio, and is now setting up its second plant adjacent to its corporate office near Kochi. Its products are exported to East Asia, the 
Middle-East, Africa, and the Americas, and the company is planning to enter European countries.


 

randox

Digital version